APRESYN
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

APRESYN Trademark

Serial Number: 97874080

APRESYN is a trademark filed by Teva Pharmaceuticals International GmbH on April 5, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals International GmbH (103 trademarks)

Schlüsselstrasse 12

Entity Type: 98

Trademark Details

Filing Date

April 5, 2023

Registration Date

Not Registered

Published for Opposition

March 19, 2024

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 15, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 15, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 12, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 11, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 11, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 11, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 30, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 30, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 30, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 30, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 14, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 14, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 14, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 14, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 14, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 1, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 1, 2024 GNFR
FINAL REFUSAL WRITTEN
Feb 1, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 1, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2023 NWOS
NEW APPLICATION ENTERED
Apr 8, 2023 NWAP